Protalix BioTherapeutics (PLX) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | -96.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.35% |
| Sep 30, 2025 | -50.21% |
| Jun 30, 2025 | -23.52% |
| Mar 31, 2025 | -28.49% |
| Sep 30, 2024 | 34.31% |
| Jun 30, 2024 | -51.44% |
| Mar 31, 2024 | -17.64% |
| Dec 31, 2023 | 38.12% |
| Sep 30, 2023 | 90.37% |
| Jun 30, 2023 | 285.72% |
| Mar 31, 2023 | 95.62% |
| Dec 31, 2022 | -56.11% |
| Sep 30, 2022 | 0.73% |
| Jun 30, 2022 | -63.13% |
| Mar 31, 2022 | -14.84% |
| Dec 31, 2021 | 8,841.51% |
| Sep 30, 2021 | -21.36% |
| Jun 30, 2021 | 599.61% |
| Mar 31, 2021 | 39.98% |
| Dec 31, 2020 | -97.55% |
| Sep 30, 2020 | -36.89% |
| Jun 30, 2020 | -80.70% |
| Mar 31, 2020 | -53.34% |
| Dec 31, 2019 | -52.94% |
| Sep 30, 2019 | -48.79% |
| Jun 30, 2019 | -11.41% |
| Mar 31, 2019 | -26.52% |
| Dec 31, 2018 | -26.10% |
| Sep 30, 2018 | 25.05% |
| Jun 30, 2018 | -17.97% |
| Mar 31, 2018 | -13.95% |
| Dec 31, 2017 | -19.15% |
| Sep 30, 2017 | -34.76% |
| Jun 30, 2017 | -36.78% |
| Mar 31, 2017 | -27.98% |
| Dec 31, 2016 | -17.14% |
| Sep 30, 2016 | 49.85% |
| Jun 30, 2016 | 26.34% |
| Mar 31, 2016 | 39.02% |
| Dec 31, 2015 | 39.45% |
| Mar 31, 2015 | -38.27% |
| Dec 31, 2014 | -36.61% |
| Mar 31, 2014 | 85.55% |
| Dec 31, 2013 | 66.04% |
| Sep 30, 2013 | 82.01% |
| Jun 30, 2013 | -44.12% |
| Mar 31, 2013 | -8.19% |
| Dec 31, 2012 | 92.72% |
| Sep 30, 2012 | 45.28% |
| Jun 30, 2012 | 34.56% |
| Mar 31, 2012 | -9.20% |
| Dec 31, 2011 | -24.79% |
| Sep 30, 2011 | -22.15% |
| Jun 30, 2011 | -19.84% |